New Delhi, July 18, 2016
Some of the key highlights are:
– The IPM grew at 13% as of on MAT June 2016
– The IPM was valued at Rs. 107,019 crores and the retail sector was valued at Rs.89,784 crores as of MAT June 2016
– All therapies have seen a dip since February 2016. However, GI (Gastro Intestinal) has shown a growth in June 2016 over May 2016
– Respiratory is the largest affected market by the ban with 71% of the value of banned drugs being contributed by 6 molecule combinations. However, Dextromethorphan + Chlorpheniramine combinations and Bromhexine combinations have shown improved growth in June 2016
Corporate Comm India(CCI Newswire)
New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…
Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…
New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…
By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…
· World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…